NS3 protein of hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner

Journal of General Virology

Volumn 87, Issue 6, 2006, Pages 1703-1713

  Deng, Lin ^a   Nagano Fujii, Motoko ^a   Tanaka, Motofumi ^a   Nomura Takigawa, Yuki ^a   Ikeda, Masanori ^b   Kato, Nobuyuki ^b   Sada, Kiyonao ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; NONSTRUCTURAL PROTEIN 3; PROTEIN P53; SERINE PROTEINASE; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; HELA CELLS; HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR SEQUENCE DATA; TUMOR SUPPRESSOR PROTEIN P53; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; HEPATITIS C VIRUS SUBTYPE 1B;

EID: 33744791738     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81735-0     Document Type: Article

References (39)

1. Appella, E & Anderson, C. W. (2001). Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268, 2764-2772.
2. Breiman, A., Grandvaux, N., Lin, R., Ottone, C., Akira, S., Yoneyama, M., Fujita, T., Hiscott, J. & Meurs, E. F. (2005). Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKε. J Virol 79, 3969-3978.
3. Cheng, P.-L., Chang, M.-H., Chao, C.-H. & Wu Lee, Y.-H. (2004). Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-β/Smad3-mediated transcriptional activation. Oncogene 23, 7821-7838.
4. Fernandez-Fernandez, M. R., Veprintsev, D. B. & Fersht, A. R. (2005). Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc Natl Acad Sci U S A 102, 4735-4740.
5. Florese, R. H., Nagano-Fujii, M., Iwanaga, Y., Hidajat, R. & Hotta, H. (2002). Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus. Virus Res 90, 119-131.
6. Foy, E., Li, K., Wang, C., Sumpter, R., Jr, Ikeda, M., Lemon, S. M. & Gale, M., Jr (2003). Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300, 1145-1148.
7. Foy, E., Li, K., Sumpter, R., Jr & 8 other authors (2005). Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A 102, 2986-2991.
8. Fuerst, T. R., Niles, E. G., Studier, F. W. & Moss, B. (1986). Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A 83, 8122-8126.
9. Fujita, T., Ishido, S., Muramatsu, S., Itoh, M. & Hotta, H. (1996). Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. Biochem Biophys Res Commun 229, 825-831.
10. Hidajat, R., Nagano-Fujii, M., Deng, L., Tanaka, M., Takigawa, Y., Kitazawa, S. & Hotta, H. (2005). Hepatitis C virus NS3 protein interacts with ELKS-δ and ELKS-α, members of a novel protein family involved in intracellular transport and secretory pathways. J Gen Virol 86, 2197-2208.
11. Ikeda, M., Abe, K., Dansako, H., Nakamura, T., Naka, K. & Kato, N. (2005). Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem Biophys Res Commun 329, 1350-1359.
12. Ishido, S. & Hotta, H. (1998). Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor. FEBS Lett 438, 258-262.
13. Ishido, S., Muramatsu, S., Fujita, T., Iwanaga, Y., Tong, W.-Y., Katayama, Y., Itoh, M. & Hotta, H. (1997). Wild-type, but not mutant-type, p53 enhances nuclear accumulation of the NS3 protein of hepatitis C virus. Biochem Biophys Res Commun 230, 431-436.
14. Kadoya, H., Nagano-Fujii, M., Deng, L., Nakazono, N. & Hotta, H. (2005). Nonstructural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter. Microbiol Immunol 49, 265-273.
15. Kao, C.-F., Chen, S.-Y., Chen, J.-Y. & Wu Lee, Y.-H. (2004). Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene 23, 2472-2483.
16. Kim, D. W., Gwack, Y., Han, J. H. & Choe, J. (1995). C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem Biophys Res Commun 215, 160-166.
17. Kim, J.-E., Song, W. K, Chung, K. M., Back S. H. & Jang, S. K. (1999). Subcellular localization of hepatitis C viral proteins in mammalian cells. Arch Virol 144, 329-343.
18. waf1 by hepatitis C virus NS3. J Gen Virol 82, 2235-2241.
19. Lan, K.-H., Sheu, M.-L., Hwang, S.-J. & 8 other authors (2002). HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21, 4801-4811.
20. Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
21. Lin, C., Prágai, B. M., Grakoui, A., Xu, J. & Rice, C. M. (1994). Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol 68, 8147-8157.
22. Loguercio, C., Cuomo, A., Tuccillo, C., Gazzerro, P., Cioffi, M., Molinari, A. M. & Del Vecchio Blanco, C. (2003). Liver p53 expression in patients with HCV-related chronic hepatitis. J Viral Hepat 10, 266-270.
23. Lohmann, V., Körner, F., Dobierzewska, A. & Bartenschlager, R. (2001). Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 75, 1437-1449.
24. Longworth, M. S. & Laimins, L. A. (2004). Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68, 362-372.
25. Martin, M. E. D. & Berk A. J. (1998). Adenovirus E1B 55K represses p53 activation in vitro. J Virol 72, 3146-3154.
26. McLure, K. G. & Lee, P. W. K. (1998). How p53 binds DNA as a tetramer. EMBO J 17, 3342-3350.
27. Moss, B., Elroy-Stein, O., Mizukami, T., Alexander, W. A. & Fuerst, T. R. (1990). New mammalian expression vectors. Nature 348, 91-92.
28. Mottola, G., Cardinali, G., Ceccacci, A., Trozzi, C., Bartholomew, L., Torrisi, M. R., Pedrazzini, E., Bonatti, S. & Migliaccio, G. (2002). Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology 293, 31-43.
29. Müller-Tiemann, B. F., Halazonetis, T. D. & Elting, J. J. (1998). Identification of an additional negative regulatory region for p53 sequence-specific DNA binding. Proc Natl Acad Sci U S A 95, 6079-6084.
30. Münger, K. & Howley, P. M. (2002). Human papillomavirus immortalization and transformation functions. Virus Res 89, 213-228.
31. Muramatsu, S., Ishido, S., Fujita, T., Itoh, M. & Hotta, H. (1997). Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J Virol 71, 4954-4961.
32. Ogata, S., Ku, Y., Yoon, S., Makino, S., Nagano-Fujii, M. & Hotta, H. (2002). Correlation between secondary structure of an aminoterminal portion of the nonstructural proteins 3 (NS3) of hepatitis C virus and development of hepatocellular carcinoma. Microbiol Immunol 46, 549-554.
33. Ogata, S., Florese, R. H., Nagano-Fujii, M. & 7 other authors (2003). Identification of hepatitis C virus (HCV) subtype 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein. J Clin Microbiol 41, 2835-2841.
34. Qadri, I., Iwahashi, M. & Simon, F. (2002). Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. Biochim Biophys Acta 1592, 193-204.
35. Reed, K. E. & Rice, C. M. (2000). Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242, 55-84.
36. Saito, I., Miyamura, T., Ohbayashi, A. & 10 other authors (1990). Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87, 6547-6549.
37. Sakamuro, D., Furukawa, T. & Takegami, T. (1995). Hepatitis C virus nonstructural protein NS3 transforms NIH3T3 cells. J Virol 69, 3893-3896.
38. Sheppard, H. M., Corneillie, S. I., Espiritu, C., Gatti, A. & Liu, X. (1999). New insights into the mechanism of inhibition of p53 by simian virus 40 large T antigen. Mol Cell Biol 19, 2746-2753.
39. Taguchi, T., Nagano-Fujii, M., Akutsu, M., Kadoya, H., Ohgimoto, S., Ishido, S. & Hotta, H. (2004). Hepatitis C virus NS5A protein interacts with 2′,5′-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J Gen Virol 85, 959-969.